Aristolochia Manshuriensis Kom Inhibits Adipocyte Differentiation by Regulation of ERK1/2 and Akt Pathway

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Kwak, Dong Hoon ^a   Lee, Ji Hye ^a   Kim, Taesoo ^a   Ahn, Hyo Sun ^a   Cho, Won Kyung ^a   Ha, Hyunil ^a   Hwang, Youn Hwan ^a   Ma, Jin Yeul ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ADIPONECTIN; ARISTOLOCHIA MANSHURIENSIS EXTRACT; ARISTOLOCHIC ACID; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; FATTY ACID SYNTHASE; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PLANT EXTRACT; PROTEIN AP2; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARISTOLOCHIA; ARISTOLOCHIA MANSHURIENSIS; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CELL STRAIN 3T3; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; GENE EXPRESSION; IN VITRO STUDY; LIPID DIET; LIPID STORAGE; MOUSE; NONHUMAN; OBESITY; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; ARISTOLOCHIA; CELL DIFFERENTIATION; CELL SURVIVAL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OBESITY; PHOSPHORYLATION; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; TRANSCRIPTION FACTORS;

ARISTOLOCHIA MANSHURIENSIS; MUS;

EID: 84869138485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049530     Document Type: Article

References (47)

1. Duvnjak L, Duvnjak M (2009) The metabolic syndrome- an ongoing story. J Physiol Pharmacol Suppl 7: 19-24.
2. Abate N, (2000) Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 14: 154-174.
3. Unger RH, Zhou YT, (2001) Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 50Suppl 1: S118-121.
4. Farmer SR, Auwerx J, (2004) Adipose tissue: new therapeutic targets from molecular and genetic studies-IASO Stock Conference 2003 report. Obes Rev 5: 189-196.
5. Fu J, Oveisi F, Gaetani S, Lin E, Piomelli D, (2005) Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 48: 1147-1153.
6. Farmer SR, (2006) Transcriptional control of adipocyte formation. Cell Metab 4: 263-273.
7. Rosen ED, MacDougald OA, (2006) Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7: 885-896.
8. Green H, Meuth M, (1974) An established pre-adipose cell line and its differentiation in culture. Cell 3: 127-133.
9. Jessen BA, Stevens GJ, (2002) Expression profiling during adipocyte differentiation of 3T3-L1 fibroblasts. Gene 299: 95-100.
10. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM, (2000) Transcriptional regulation of adipogenesis. Genes Dev 14: 1293-1307.
11. Arnott CH, Atkinson PG, Sale EM, Sale GJ, (1997) PHAS-I phosphorylation in response to foetal bovine serum (FBS) is regulated by an ERK1/ERK2-independent and rapamycin-sensitive pathway in 3T3-L1 adipocytes. FEBS Lett 406: 179-183.
12. Hu E, Kim JB, Sarraf P, Spiegelman BM, (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274: 2100-2103.
13. Sale EM, Atkinson PG, Sale GJ, (1995) Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J 14: 674-684.
14. Tang QQ, Otto TC, Lane MD, (2003) Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci U S A 100: 44-49.
15. Hung PF, Wu BT, Chen HC, Chen YH, Chen CL, et al. (2005) Antimitogenic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways. Am J Physiol Cell Physiol 288: C1094-1108.
16. Liao QC, Li YL, Qin YF, Quarles LD, Xu KK, et al. (2008) Inhibition of adipocyte differentiation by phytoestrogen genistein through a potential downregulation of extracellular signal-regulated kinases 1/2 activity. J Cell Biochem 104: 1853-1864.
17. Prusty D, Park BH, Davis KE, Farmer SR, (2002) Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277: 46226-46232.
18. Xu J, Liao K, (2004) Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation. J Biol Chem 279: 35914-35922.
19. Magun R, Burgering BM, Coffer PJ, Pardasani D, Lin Y, et al. (1996) Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 137: 3590-3593.
20. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, et al. (2003) Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17: 1352-1365.
21. Farnsworth, N.R., 1998, The Napralert Database. University of Illiois at Chicago, IL.
22. Yang XC, (1986) [Exploratory study on various parts of Aristolochia manshuriensis for medical use]. Zhong Yao Tong Bao 11: 19-21.
23. Yang L, Li X, Wang H, (2007) Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis. Nephrol Dial Transplant 22: 445-456.
24. Pozdzik AA, Salmon IJ, Husson CP, Decaestecker C, Rogier E, et al. (2008) Patterns of interstitial inflammation during the evolition of renal injury in experimental aristolochic acid nehropathy. Nephrol Dial Transplant 23: 2480-2491.
25. Rayalam S, Della-Fera MA, Baile CA, (2008) Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem 19: 717-726.
26. Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, et al. (2005) Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338: 694-699.
27. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS, (1988) Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263: 9402-9408.
28. Xing Y, Yan F, Liu Y, Zhao Y, (2010) Matrine inhibits 3T3-L1 preadipocyte differentiation associated with suppression of ERK1/2 phosphorylation. Biochem Biophys Res Commun 396: 691-695.
29. Aubert J, Dessolin S, Belmonte N, Li M, McKenzie FR, et al. (1999) Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. J Biol Chem 274: 24965-24972.
30. Cornelius P, MacDougald OA, Lane MD, (1994) Regulation of adipocyte development. Annu Rev Nutr 14: 99-129.
31. Kohn AD, Summers SA, Birnbaum MJ, Roth RA, (1996) Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378.
32. Uto-Kondo H, Ohmori R, Kiyose C, Kishimoto Y, Saito H, et al. (2009) Tocotrienol suppresses adipocyte differentiation and Akt phosphorylation in 3T3-L1 preadipocytes. J Nutr 139: 51-57.
33. Kim YK, Choi HY, Kim NH, Lee W, Seo DW, et al. (2007) Reversine stimulates adipocyte differentiation and downregulates Akt and p70(s6k) signaling pathways in 3T3-L1 cells. Biochem Biophys Res Commun 358: 553-558.
34. Zhu X, Zhou F, Qin D, Zeng Y, Lv Z, et al. (2011) Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-kappaB signaling pathways. J Mol Biol 410: 1035-1051.
35. Liu Y, Gao X, Deeb D, Gautam SC, (2012) Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells. Biochem Biophys Res Commun 417: 570-575.
36. Su z, Xu S, Zheng F, Li Y, (2002) Aristolochic acid induced transdifferentiation and apoptosis in human tubular epithelial cells in vitro. Zhonghua Yu Fang Yi Xue Za Zhi 36: 301-304.
37. Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM, (2001) Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem 276: 34167-34174.
38. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM, (1994) mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8: 1224-1234.
39. Yeh WC, Cao Z, Classon M, McKnight SL, (1995) Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9: 168-181.
40. Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, et al. (2002) C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 16: 22-26.
41. Hou Y, Xue P, Bai Y, Liu D, Woods CG, et al. (2012) Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein beta during adipogenesis. Free Radic Biol Med 52: 462-472.
42. Tang QQ, Otto TC, Lane MD, (2003) CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci U S A 100: 850-855.
43. Hiuge-Shimizu A, Maeda N, Hirata A, Nakatsuji H, Nakamura K, et al. (2011) Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone. Arterioscler Thromb Vasc Biol 31: 792-799.
44. Liu LH, Wang XK, Hu YD, Kang JL, Wang LL, et al. (2004) Effects of a fatty acid synthase inhibitor on adipocyte differentiation of mouse 3T3-L1 cells. Acta Pharmacol Sin 25: 1052-1057.
45. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, et al. (1996) PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15: 5336-5348.
46. Seo JB, Park SW, Choe SS, Jeong HW, Park JY, et al. (2012) Foenumoside B from Lysimachia foenum-graecum inhibits adipocyte differentiation and obesity induced by high-fat diet. Biochem Biophys Res Commun 417: 800-806.
47. Huang C, Zhang Y, Gong Z, Sheng X, Li Z, et al. (2006) Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem Biophys Res Commun 348: 571-578.